Ziemer USA, Inc., a wholly owned subsidiary of Ziemer Group AG (Port, Switzerland), a developer and manufacturer of the Femtosecond Laser Technology (FEMTO LDV Z8) and Corneal Diagnostic equipment (GALILEI ColorZ), announces the introduction of GALILEI ColorZ with ZEISS VERACITY Surgical compatibility.
"We continue to invest in new technologies making it easier for our customers and surgeons to deliver great patient outcomes every day. We are excited about the upgrades we have made with the GALILEI ColorZ and the connectivity offered with ZEISS VERACITY Surgical", says David Bragg, President of Ziemer USA & Canada.
The GALILEI ColorZ G4 and G6 represent the new generation of the renowned diagnostic platform, offering multilayer TopView images in vibrant colors and high contrast to provide enhanced visualization of numerous details including blood vessels, iris patterns and the pupil. Now, with access to ZEISS VERACITY Surgical, the GALILEI ColorZ G6 is the all-in-one device that takes refractive cataract surgery planning to the next level.
ABOUT ZIEMER USA, INC.
Ziemer believes in constantly innovating and improving technology to better serve our doctors. Our Swiss-engineered femtosecond lasers are uniquely designed to perform multiple procedures and give patients a safe and seamless experience. Our GALILEI ColorZ diagnostic devices are now ZEISS VERACITY Surgical compatible and will give you precise measurements to enhance your treatment planning.
Northwell Holdings, the for-profit investment arm of Northwell Health, New York State's largest healthcare provider and private employer, today announced a strategic investment of $3 million in Hume AI, a leading expressive communication research lab and technology company. The investment aims to address the growing demand for scientific tools to understand language and nonverbal expression in the healthcare industry. Hume AI plans to use the funding to refine their advanced machine learning models for use in health applications, including clinical research, patient screening, and accessibility technology.
These models, accessible through Hume AI's integrated platform, address a significant shortcoming of natural language understanding (NLU) tools, which convert speech into text. NLU tools overlook how the meaning of speech can be transformed dramatically by its tune, rhythm, and timbre, along with nonverbal utterances such as laughs, sighs, and gasps. Such features are particularly important for understanding health conditions such as pain, major depression, and cognitive impairment. With NLU rapidly being integrated into healthcare applications, Hume AI's platform will enable a more accurate understanding of expressive communication at every step of the patient's journey, from screening to diagnosis and treatment.
"Technologies that draw upon the latest scientific research to help us better understand not just what people say, but how they say it, have profound potential to benefit patients," said Rich Mulry, CEO and President of Northwell Holdings. "We already see rising demand for this technology in treatment, clinical research, telehealth applications and more. To promote the careful development of these potentially transformative technologies, we are excited to launch our partnership with Hume AI through an investment that reflects our confidence in Dr. Alan Cowen and his groundbreaking team."
Hume AI builds its models using new peer-reviewed scientific research and algorithms designed to minimize bias. Previous technologies for understanding nonverbal expression have focused on the expression of six emotions—happiness, sadness, anger, disgust, fear, and surprise—based on established psychological models. Scientific research published in leading journals by Hume AI's founder and CEO Dr. Alan Cowen, Chief Scientific Advisor Dr. Dacher Keltner, and colleagues has given rise to a more nuanced theory of human expressive behavior. Known as semantic space theory, this work documents how expressions involve complex patterns in language, speech prosody, nonverbal vocalizations like sighs and chuckles, and movement in more than 30 facial muscles. To translate this research into effective machine learning models, Cowen and his team have collected new experimental data from around the world that allow them to characterize the nuances of expressive communication within and across cultures with less bias and more precision.
"In recent years, there have been major scientific advances in our understanding of expressive communication," Cowen said. "For the first time, we can equip researchers and practitioners in the healthcare space with objective, nuanced, and multidimensional measures of human expression. We are deeply grateful to Northwell Holdings for recognizing the extraordinary potential of this new technology to improve people's lives and address health inequities. Our partnership will support translational researchers studying how expressive signals relate to mood, mental health, and pain in neuropsychiatric disorders, as well as customers developing new interventions to restore emotional intonation to speech aids, annotate emotional context, and guide empathic behavior."
Hume AI is a leading expressive communication research lab and startup with a mission of aligning technology with human well-being. Based on scientific research that reveals a broader spectrum of expressive behavior than previously known, Hume AI offers the world's most accurate and comprehensive tools for understanding nonverbal expression, including speech prosody, vocalizations like sighs, and facial expressions. Led by founder and CEO Dr. Alan Cowen, an established expert in the field of affective science, Hume AI develops its models using new scientific research that it conducts and regularly publishes in leading journals. The company provides its datasets and models through a unified API platform. Learn more about Hume AI at www.hume.ai and follow us on LinkedIn and Twitter.
About Northwell Holdings
Northwell Holdings ("Holdings"), a fully owned, for-profit subsidiary of Northwell Health, creates value for the health system by investing in early-stage companies, establishing commercial joint ventures, cultivating internally-developed ideas and bringing them to market, and advancing data partnerships that drive innovation in patient care, health diagnostics, and deep technology. We invest in companies that are aligned with Northwell's mission, promote better health outcomes, improve patient experience, and increase efficiencies in care delivery and services. Through strategic partnerships, Holdings leverages the health system's robust enterprise data assets to develop AI-enabled solutions that address healthcare inequities. We combine Northwell Health's clinical and healthcare business expertise and entrepreneurial spirit to bring concepts to life. Northwell Health is New York's largest healthcare system. To learn more, visit us here and follow us on LinkedIn.
Supporting up to 7 GPUs for Higher Density Workloads
FREMONT, Calif. - September 29, 2022 - (Newswire.com)
AMAX, a leading provider of customized rack-scale High-Performance Computing (HPC) solutions and server appliance manufacturing, announces the new LiquidMax™ LA-2 workstation supporting the AMD 3rd Gen EPYC™ 7003 CPU series with AMD 3D V-Cache™ technology and up to 64 cores to its LiquidMax™ series of liquid-cooled workstations. The LA-2 boasts the capability to support up to seven NVIDIA A100 or A6000 GPUs for increased HPC power to complete high-density workloads faster. It is an intelligent GPU workstation for enterprise and research infrastructures that need to accelerate deep learning training and scientific visualization applications. With the introduction of the LA-2 by AMAX, researchers can work with large datasets at interactive speeds without dependency on expensive cloud platforms or competing resource allocation from on-premise clusters.
The ultra-quiet LiquidMax™ LA-2 provides the most powerful and eco-friendly platform in convenient workstation form, backed by a full warranty with global tech support for peace of mind. The single CPU LA-2 features a single root topology to maximize GPU to GPU bandwidth, up to 4TB of DDR4 system memory, and up to 176TB of raw storage across 8 hot-swappable WD Gold® Enterprise Class Hard Drives for maximum storage capacity. The user-friendly turnkey design showcases AMAX's engineering expertise with a proprietary enterprise-grade liquid cooling system featuring custom patented CPU and GPU cold plates for more efficient thermal management and dual Gold® rated power supplies. The chassis includes durable casters for mobility and real-time LED display monitoring of key safety functions.
The expansion of the LiquidMax™ series by AMAX with the LA-2 data science workstation provides unrivaled flexibility of configuration and performance options to meet growing HPC demands at any scale. For more information on the LA-2 and to view the full spectrum of advanced liquid-cooled solutions by AMAX, visit us here.
About AMAX AMAX is an award-winning global leader in data center, open-architecture platforms, HPC, deep learning, application-tailored cloud, and OEM server manufacturing solutions designed toward the highest efficiency and optimal performance. Whether you are a Fortune 100 company seeking significant cost savings through better efficiency for your global data centers or a software startup seeking an experienced manufacturing partner to design and launch your flagship product, AMAX is your trusted solutions provider, delivering the results you need to meet your specific metrics for success. For more information about AMAX and our commitment to the highest standards of quality, design, and support, learn more about us here.
Contact Information:
Vily Vu
Marketing Manager [email protected]
800.800.6328
The noted Atlanta, Georgia urgent care, along with providing the new COVID-19 vaccine, offers need-to-know knowledge about the booster that targets Omicron subvariants, BA.4 and BA.5.
In November 2021, the World Health Organization (WHO) labeled what we now know as the Omicron variant as a Variant of Concern. The ease of transmissibility was unlike previous forms of COVID-19, leading to a monumental surge in the United States.
In WestsideMed's home state of Georgia, the Omicron variant was especially transmissible.
"In fact, in Georgia, health systems experienced a staggering 100% to 200% hospitalizations in a weeklong period in late December 2021. And we experienced much of the same with the newer Omicron subvariants," says Esteves.
After the initial wave of the Omicron surge in 2021 and early 2022, two subvariants, BA.4 and BA.5, appeared in late spring and early summer.
"And Omicron's transmissibility and virulence increased with the spread of the dominant BA.4 and BA.5 subvariants," Esteves continues. "With them, the ease of transmissions via spike protein mutations has increased significantly."
Ariel Esteves assures Atlantans that this booster promises to bolster immune responses to the new subvariants.
"While these subvariants are more resistant to antibodies of the original virus, your body willrecognize BA.4 and BA.5," says Esteves. "In short, being vaccinated will still give you protection against severe illness and death."
Along with dispensing medical advice on its blog, WestsideMed provides quick, safe, and effective medical care in its Atlanta location on Marietta Boulevard.
With its team of talented medical providers, led by emergency medicine & family nurse practitioner Ariel Esteves, the Atlanta urgent care ensures that patients needing a quick medical fix are within their grasp.
Whether it's a quick checkup to ensure optimal health, treating sports injuries, or giving EKG readings in Atlanta, the urgent care promises to provide a safe environment for everyone.
The new round of COVID-19 bivalent boosters is just one more way to effortlessly take care of one's health at this Atlanta urgent care.
Contact Information:
Ariel Esteves
Emergency Medicine & Family Nurse Practitioner [email protected]
217-269-8205
Roadpass Digital, the company empowering roadtrippers, campers, and RVers to hit the open road, has added new Roadpass University courses to help RVers this autumn and winter. Roadpass University houses a library of online courses led by RV experts across a variety of topics relevant to RV ownership, from brand-new RVers to seasoned, full-time road warriors.
The new courses that are now available in Roadpass University include:
Introduction to RV Ownership: This course guides a user through the first year of owning an RV, offering tips on everything from picking up a new RV from the dealer to winterizing and long-term storage.
RV Maintenance Made Easy: This course offers troubleshooting and maintenance tips for some of the most important systems and appliances in your RV. With these preventative maintenance tips, RVers can stay ahead of regular wear and tear before it becomes a bigger problem.
"As the temperature cools, we're here to ensure our community of RVers are well-prepared and know the ins and outs of their RV," said Stephanie Puglisi, Vice President of Content at Roadpass Digital. "Roadpass University's library of courses is the best way to quickly gain the knowledge you need, so you can make the most of your RV."
Enrollment in Roadpass University is free. Courses are offered in two formats depending on the complexity of the subject matter: shorter bootcamps and longer in-depth courses. Courses include videos, PDFs, downloadable checklists, and quizzes. Other topics range from RV shopping, an introduction to campgrounds and boondocking, campground etiquette, RV organization tips, and an introduction to RV power, including solar 101. New courses are being added regularly to the Roadpass University website. Future topics will include trip planning, renting an RV, and more.
Roadpass Digital offers a portfolio of leading digital apps that provide campers, RVers, and roadtrippers with end-to-end trip discovery and planning tools. Roadpass Digital's brands include Roadtrippers, Campendium, Togo RV, and RVillage.
Roadpass Digital is focused on empowering roadtrippers, campers, and RVers to hit the open road. With 6,000,000+ people using apps powered by Roadpass, the company is the leading platform for road travel and outdoor experiences. Roadpass Digital has offices in Chicago, Cincinnati, and Auckland. Learn more about Roadpass Digital and Roadtrippers, Campendium, Togo RV, and RVillage products at roadpass.com.
William H. Harris, MD, Honored for His Six-Decade-Long Career in Orthopaedics and Transformative Contributions in the Field of Hip Replacements
EVERETT, Mass. - September 29, 2022 - (Newswire.com)
Orthopaedic Summit Evolving Techniques (OSET), the non-profit organization dedicated to educational advancement in orthopaedics, with Orthopaedic Surgeon Wayne G. Paprosky, MD (pictured at far left) from Rush Presbyterian-St. Luke's Medical Center, presented the Lifetime Achievement Award to 94-year-old William H. Harris, MD, (pictured at far right) Founder and Director Emeritus of the Massachusetts General Hospital, Harris Orthopaedics Laboratory. (Pictured second from left) is Orthopaedic Surgeon Kevin D. Plancher, MD, MPH, Founder of OSET and Ivan Tornos, President & COO of Zimmer Biomet (pictured third from left).
Dr. Harris will forever be known for his invention of the Harris Hip Score (HHS), used for evaluating patient-reported outcomes in hip arthroplasty and later his important discovery into effective prevention of Deep Vein Thrombosis (DVT) after hip surgery, which has saved many lives. His laboratory helped unravel a totally new, destructive disease damaging total hip and total knee reconstruction. They then innovated a new material, which improved the new prosthetic bearing surface, eliminating that bone destruction and greatly extending the life of total joint implants. His Harris Harvard Hip Course was the seminal course that set the bar for education in total joints for years to come.
###
ABOUT ORTHOPAEDIC SUMMIT EVOLVING TECHNIQUES
Orthopaedic Summit Evolving Techniques (OSET) is a 501c3 organization founded by Orthopaedic Surgeon, Kevin D. Plancher, MD, MPH, FAOA, FAAOS, FACS, and Conference Chair, Brian D Busconi, MD of UMASS Medical Center in 2010. OSET is accredited by the ACCME for Continuing Medical Education (CME) Credits and Accredited by the American Physical Therapy Association MA (APTA) for Continuing Education Units (CEU) for Healthcare Professionals. OSET is committed to advancing the education of healthcare professionals by providing an educational platform that includes hands-on training, live surgeries, and didactic presentations in the musculoskeletal field, including all orthopaedic, sports medicine and sports rehab specialties. www.orthosummit.com
Contact Information:
Fred Yaeger
President [email protected]
914 525 9198
CASABLANCA, Morocco - September 29, 2022 - (Newswire.com)
Today, UM6P Ventures announced its investment in Infiuss Health. The startup is developing a decentralized SaaS platform to power remote research and clinical trials in Africa.
Pharmacological companies attempt to include a large and varied population within their phased trial cohorts to prove their medical thesis. However, Africans, a significant group of genetically diverse participants, are not traditionally well represented within their demographic profile, rendering their trial outcomes potentially skewed.
There is a need for researchers to select a wider range of people from different demographics to participate in clinical research to reduce bias, promote health equity, and produce innovative scientific findings.
To date, Africa's participation is only a small percentage of the global clinical trials landscape, as a result of the regulatory and ethical implications of clinical trials. To that end, several individual regulatory bodies have joined efforts to ensure that clinical trials in African countries are conducted in accordance with international best clinical practices and ethical standards. Thus, with new regulatory structures in place in Africa, medicinal effectiveness and availability will be improved. In fact, Infiuss Health only services sponsors that have previously been approved by the U.S. FDA, which ensures that trials comply with the exacting framework required by U.S. regulations.
Infiuss Health provides clinical trial access to African participants and allows pharmaceutical companies to conduct and monitor these trials via the Infiuss Health Probe Platform. Through their direct-to-participant approach, they help corporate and academic researchers diversify their cohorts by connecting them directly to thousands of eligible African participants to take part in their clinical studies.
"Our main mission is to make clinical research accessible to all Africans. We're very pleased to have UM6P Ventures' support as Infiuss Health continues to grow African clinical trials that will have enormous benefits, including improved healthcare and patient outcomes.", stated Melissa Bime, CEO and Founder of Infiuss Health.
Through a single dashboard, the all-in-one software platform helps companies identify and select the right sites for trials, manage the entire research process, remotely recruit participants, collect remote consent, gather, and analyze data and provide virtual support faster and cheaper than third-party contract research organizations.
"The clinical trial phase is decisive in the pharmacological development lifecycle. This is a branch of our Healthtech investment thesis that we have been actively investigating. The Infiuss Health team brings a solution, expertise, and experience that adds critical elements to our health science and technology ecosystem. We are confident in their ability to deliver on their value proposition and contribute to the improvement of the health system in Africa," said Yasser Biaz, CEO of UM6P Ventures.
A leader in East Coast cannabis, Theory Wellness announced plans to open in their third state to bring their world-class retail operations to the blossoming Vermont cannabis industry.
STONEHAM, Mass. - September 29, 2022 - (Newswire.com)
Theory Wellness ("Theory" or "the Company") has announced plans to enter the Vermont recreational cannabis market with a retail location in Brattleboro. The announcement comes on the eve of recreational cannabis sales, expected to begin as early as October 1. Vermont will soon become the third East Coast state to offer recreational cannabis sales.
Theory is no stranger to emerging recreational cannabis markets, being one of the first in Massachusetts and opening on day one of adult-use cannabis sales in Maine. However, unlike in the other states, they intend to focus on retail, a pivot from their vertically integrated models in surrounding markets.
"Vermont is one of the most interesting regulatory models on the East Coast for cannabis. The emphasis on streamlined licensing for craft farmers will allow for a terrific mix of top-quality products in our dispensary. By focusing on retail, we look forward to showcasing to our customers this unique network of local cultivators, many of which have been producing high-quality flower for years," shares Brandon Pollock, CEO of Theory Wellness.
As of today, the Vermont Cannabis Control Board has approved over 200 licenses for cultivation sites across the State. Theory looks forward to serving customers with its location at 768 Putney Road, currently under construction. The location will add new jobs to the town in addition to contributions relating to the 14% in excise taxes on sales.
While there is no official opening date for their Brattleboro dispensary, the Company expects to be operational this fall. Their progress and status of the retail location can be found on their website.
About Theory Wellness
Theory Wellness is an independently owned and operated cannabis company that cultivates and manufactures cannabis, and serves patients and consumers in Massachusetts, Maine, and soon-to-be Vermont. Theory sources unique genetics and creates premium products that include flower, concentrates, edibles and infusions, and brands. For more information, visit https://theorywellness.org/.
Contact Information:
Thomas Winstanley
Chief Marketing Officer [email protected]
4138229054
BETHESDA, Md. - September 28, 2022 - (Newswire.com)
Gardyn is proud to be a part of the White House Conference on Hunger, Nutrition, and Health on Sept. 28, 2022, to showcase its Gardyn Home technology. This conference is a unique opportunity to mobilize all stakeholders to address one of the most pressing issues in the U.S.: diet-related diseases.
"Gardyn's mission has always been to help everyone have a healthy lifestyle, sustainably," says FX Rouxel, Gardyn CEO. "We believe in the urgent need to make healthy food easily accessible and affordable for everyone, everywhere. Food deserts should be no more in this new century. Educating kids early on about healthy habits and real food is the best way to build healthy habits as they grow into adults."
The technologies Gardyn is developing, based on artificial intelligence, make it possible for everyone to grow healthy food at home, with no green thumb, time, or space required. Gardyn Units successfully grow high yields of nutrient-dense and pesticide-free produce within only two square feet, using 95% less water than traditional agriculture. The result is enough food to feed a family of four, allowing for a healthier lifestyle that is also better for the environment. This home-grown-food revolution is instrumental in reimagining what a healthier future should look like for everyone.
Promoting and providing access to healthy food is paramount in the U.S. as diet-related diseases, including heart disease, obesity, and type 2 diabetes, are a leading cause of death and disability in our country. More than 1 death out of 5 is due to a poor diet. According to the CDC, of U.S. adults, 96 million — more than 1 in 3 — have prediabetes, and 42% have obesity. Fewer than 1 in 10 adolescents and adults eat enough fruits or vegetables. We believe that Gardyn can help everyone develop healthy habits in an accessible and sustainable way.
About Gardyn
Gardyn reimagines the future of food. Through the development of cutting-edge patented Hybriponic technology, Gardyn makes growing large quantities of nutritious food convenient. This technology makes it possible to grow produce in your home with limited maintenance in a fully local and highly sustainable way. After several years of research and development in partnership with universities, Gardyn launched the revolutionary "Gardyn Home" device and its innovative gardening assistant KelbyⓇ, which won several awards and garnered broad media attention.
About the Conference on Hunger, Nutrition, and Health
The Biden-Harris Administration will host the White House Conference on Hunger, Nutrition, and Health on Sept. 28, 2022. In parallel to the conference, the administration has released a National Strategy that identifies steps the government will take and catalyzes the public and private sectors to address the intersections between food, hunger, nutrition, and health.
It's been more than 50 years since the first and only White House Conference on Food, Nutrition, and Health was held in 1969. That pivotal event helped galvanize actions that included the creation of life-changing programs like school lunches, the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC), and changes to how we label foods.
EAST LANSING, Mich. - September 28, 2022 - (Newswire.com)
Refresh IV Bar, a privately-owned provider of IV vitamin therapy services, will celebrate the opening of its new clinic in Haslett on Saturday, Oct. 1. The clinic is located at 2119 Haslett Road Ste B, Haslett, MI 48840. The location offers a complete menu of IVs to provide a variety of support including migraine relief, weight loss, mood balancing, pregnancy, hangover recovery, healthier complexion, hydration, sports performance and more.
"We've been pleasantly surprised by how interested the community has been since we've begun advertising the grand opening," said Lara Hakamaki, Refresh IV Bar's Director of Corporate Development.
Hakamaki joins Meridian Area Business Association's President Nate Kirk to host a ribbon-cutting on October 1 at noon. Following the ribbon-cutting, guests will be invited to take guided tours of the clinic during an open house that lasts until 1 p.m. Guests will have an opportunity to meet Hakamaki and other members of the IV bar's team.
"As part of the Refresh IV Bar's grand opening, we are offering a limited-time offer for the month of October. To help the Lansing community achieve their health and wellness goals, all Refresh IV Bar customers receive 25% off their first infusion," said Hakamaki.
Refresh IV Bar plans to expand in the near future and is welcoming community feedback.
Self-pay by credit card is the only form of payment accepted at this time. Call 517-708-7499 to schedule your experience or visit https://RefreshIV.bar to learn more.
###
ABOUT REFRESH IV BAR
The team at Refresh IV Bar wants you to be able to live your best life and that means helping you feel your happiest and healthiest as soon as possible. Our IV therapy treatments take about 45 minutes and have been created to help you feel your best. You will receive the absolute highest quality care and treatment with every visit to our facility. Our environment prioritizes comfort and ease, so you can relax and focus on feeling better and finding rejuvenation. Sit back, relax with one of our complimentary beverages, and allow yourself to find healing today. Come in and feel refreshed. https://RefreshIV.bar
Contact Information:
Lara Hakamaki
Director of Corporate Development [email protected]
(989) 292-3572
